JSF Financial’s ALX Oncology ALXO Stock Holding History

JSF Financial’s Portfolio ALXO Stock Details ALXO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$36.2K	Hold	17,500	–	–	0.01%	141
2026 Q1	$35.1K	Hold	17,500	–	–	0.01%	126
2025 Q4	$19.8K	Hold	17,500	–	–	﹤0.01%	132
2025 Q3	$32K	Hold	17,500	–	–	0.01%	128
2025 Q2	$7.26K	Hold	17,500	–	–	﹤0.01%	128
2025 Q1	$10.9K	Hold	17,500	–	–	﹤0.01%	120
2024 Q4	$29.2K	Buy	+17,500	New	+$26.9K	0.01%	121

Other funds holding ALXO

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

PFSRSONJ

Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

AHL

Abel Hall LLC Baton Rouge, Louisiana $579M AUM 54.21% 1-Year Est. Return

CUAMC

China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return

EWA

EverSource Wealth Advisors Birmingham, Alabama $2.97B AUM 28.74% 1-Year Est. Return

SCM

Sterling Capital Management Charlotte, North Carolina $5.9B AUM 29.63% 1-Year Est. Return

SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return

JSF Financial's ALXO Position: Q2 2026 in Review

JSF Financial held its ALX Oncology (ALXO) position steady in Q2 2026 at 17,500 shares worth $36.2K. The position accounts for 0.01% of the portfolio, ranked #141.

JSF Financial first reported a position in ALXO in Q4 2024 and has held it in 7 quarters since. 10 funds tracked by Wall St. Rank hold ALXO as of Q2 2026.

JSF Financial held 17,500 shares of ALX Oncology worth $36.2K as of Q2 2026.
JSF Financial left its ALX Oncology share count unchanged in Q2 2026.
ALX Oncology made up 0.01% of JSF Financial's portfolio in Q2 2026, its #141 holding.
JSF Financial first reported a position in ALX Oncology in Q4 2024 and has held it in 7 quarters since.
10 funds tracked by Wall St. Rank held ALX Oncology as of Q2 2026.

Based on JSF Financial's 13F filing for Q2 2026, filed 28 Jul 2026.